Safety Layer Modulation for Diabetes Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diabetes management systems lack modularity and user flexibility, particularly in closed-loop systems, where users are restricted from self-medication and may experience insulin delivery limitations due to safety protocols that do not account for user-initiated commands or hardware/software upgrades.
Innovation Solution
An integrated diabetes management system with a safety layer that modifies glucose data and insulin delivery signals to ensure safe and accurate insulin delivery, allowing user intervention while maintaining safety and compatibility with various system components, including a glucose sensor, delivery device, and controller.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a closed-loop system is implemented with strict safety protocols, then system safety is improved, but user flexibility and ability to self-medicate deteriorates
Solution Approach 1:
The patent introduces a handheld device as an intermediary between the automated pump system and the user. This device allows users to input self-medication commands and receive system status information, serving as a communication bridge that enables user flexibility while maintaining the safety protocols of the closed-loop system. The handheld device processes user intentions and translates them into system-compatible commands without compromising the underlying safety architecture.
2Measurement precision
If system components are tightly integrated, then system accuracy and control are improved, but system modularity and adaptability to upgrades deteriorates
Solution Approach 1:
The patent divides the diabetes management system into distinct modular components: a glucose sensor, a pump, a controller, and a handheld device. Each component can be independently developed, upgraded, or replaced while maintaining standardized communication interfaces. This segmentation allows for tight integration and high accuracy within each module while preserving overall system modularity and adaptability to hardware or software upgrades.
3Object-affected harmful factors
If safety limits are enforced on insulin delivery, then user protection from under- or over-dosage is improved, but user control and ability to self-medicate deteriorates
Solution Approach 1:
The system implements preliminary safety checks and validation mechanisms that prevent harmful insulin dosage errors before they can occur. The controller and handheld device verify user commands against predefined safety parameters, such as maximum delivery rates and cumulative dosage limits, before executing insulin delivery. This preliminary anti-action protects users from dosage errors while still allowing them to initiate and control their own self-medication decisions.
Data Source
AI summary
An integrated diabetes management (IDM) system includes a safety layer which, in one configuration has two components, one located between a glucose sensor and a controller and a second component located between a controller and a pump, to monitor various aspects of signals and modify those signals for compatibility and safety purposes. In one application, the safety layer receives output control signals from a controller and modifies those control signals as a function of an actual amount of insulin delivered to the user. The safety layer allows for an increased level of safety in the IDM system and permits development of separate hardware and software upgrades with the safety layer assuring that compatibility between components will continue.